Clinical Trials Logo

Clinical Trial Summary

To assess the incidence, risk factors and clinical courses of cystic macular lesions (CMLs) after uncomplicated phacoemulsification and evaluate the efficacy of topical NSAIDs on the prevention of pseudophakic cystic macular lesions


Clinical Trial Description

344 Patients undergoing uncomplicated standard phacoemulsification at Kyungpook National University Hospital from 2013 to 2015 were reviewed. CMLs, which is any cystic fluid collections after cataract surgery, were confirmed by preoperative and postoperative optical coherence tomography(OCT) on preoperative, postoperative 1month and 3months examinations. CMLs were classified into two groups: cystic macular edema(CME) and microcystic macular edema(MME). ;


Study Design


Related Conditions & MeSH terms

  • Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification

NCT number NCT03106402
Study type Observational
Source Kyungpook National University
Contact
Status Completed
Phase N/A
Start date October 1, 2013
Completion date July 30, 2015